SlideShare a Scribd company logo
ROLE OF IHC IN
TESTICULAR TUMORS
BY: DR. PRERNA CHOUDHARY
TESTIS- ANATOMYandHISTOLOGY
Measures- 4.5 X 2.5 X 3 cm ; weighs:20 gram
INTRODUCTION
•Testicular cancers are the most common solid malignancy and the second leading
cause of cancer death in young men
•Affecting males between the ages of 15 and 35, although they represent only
approximately 1 percent of all solid tumors in men
•The are classified as per WHO CLASSIFICATION OF TUMORS OF TESTIS 2016
•THE H&E is gold standard for diagnosis, IHC plays a significant role and <5% of tumors
require Immunostaining for accurate interpretation.
•Differential diagnosis can be resolved with IHC
•BUT, few pre-analytical errors to be kept in mind
PREANALYTICAL ERRORS
IHC is very important for diagnosis of type of cancer, however there can few errors which give
false results
FALSE NEGATIVE:
Antibody inappropriate, denatured , used at wrong concentration
Loss of antigen through poor fixation/diffusion.
Presence of antigen at a density below level of detection.
FALSE POSITIVES:
Cross- reactivity of antibody with unintended antigens
Nonspecific binding of the antibody to the tissue
Presence of endogenous peroxidase
Entrapment of normal tissues by tumor cells
GERM CELL TUMORS
Non-invasive GCN
GERM CELL NEOPLASIA IN SITU
•Syn – Intratubular germ cell neoplasia, unclassified;
testicular intraepithelial neoplasia
•Derived from primordial germ cells/gonocytes that failed to
differentiate into spermatogonia
• Adult testis – inside seminiferous tubules, between sertoli
cell and basal membrane;
•infantile testis - GCINS cells detached from basal membrane
•No. tubules affected – few to 100% (variable)
•Gonocyte-like germ cells - clear cytoplasm; angulated nuclei;
coarse chromatin ,base of tubules
•Nuclei - string of beads – separated from the lumen of
tubule – by uniform sertoli cell nuclei
IHC – PLAP (cytoplasmic), OCT3/4(NUCLEAR), Podoplanin, NANOG, LIN28 (absent – normal
spermatogonia), SALL4
KIT(CD117) – non specific; normal spermatogonia – may be positive (cytoplasmic
membrane)
Frozen section – Alkaline phosphatase – helpful
EMA, CD30, GLYPICAN 3, SOX2
•DD
Vacolization of seminiferous tubule cells (degenerative change)
Maturation arrest in spermatogonia
Metastatic carcinoma- melanoma, lymphoma may colonize seminiferous tubules
OCT ¾ - resolve this matter
Marker with normal tissues expressing type dd
Oct ¾ (Octamer-binding transcription
factor 4)
Is not expressed in normal,
differentiated cells
nuclear • Highly sensitive and specific for seminoma
• Poor prognostic factor for esophageal squamous cell
carcinoma
• May be poor prognostic factor for non-small cell lung
cancer
• MAY LOOSE REACTIVITY AFTER CHEMOTHERAPY
PLAP (Placental Alkaline Phosphatase)
placenta
Cytoplasmic • Germ cell tumors(does not stain spermatocytic seminoma)
• Intratubular germ cell neoplasia
• Trophoblastic tumors
• Serum PLAP is increased 10 fold in smokers- so not always
included in diagnostic workup
Podoplanin (D2-40)
Novel marker of mesothelial cells,
germ cells, lymphatic endothelial cells
membranous Seminoma (100%)
Embroyonal carcinoma (30%)
Others: mesothelioma
dermatofibroma
Hemangioblastoma
Primary skin adnexal tumor
Marker with normal tissues
expressing
type dd
SALL4
Embryonic stem cells
Nuclear Pan germ cell tumor marker
CD117(stem cell factor receptor)
Germ cells
Cytoplasmic and membranous • Seminoma
• Intratubular germ cell neoplasia
Others: Gist
PEComas
Oncocytomas
CD 30 Membranous and golgi(paranuclear
dot like)
Embryonal carcinoma
Specificforms – Intratubulargermcellneoplasia
Intratubular seminoma – complete filling of tubules
by neoplastic cells (identical to seminoma, GCINS),
lymphocytes present
IHC – simillar to seminoma
Intratubular non – seminoma – almost always
embryonal carcinoma
Distortion of tubules , enlarged beyond normal
diameter, necrosis, calcification
IHC – OCT3/4 +, CD 30 +, CD 117 –
(CD 30 is negative in GCNIS)
INVASIVE GCN- single histological type
Seminoma
•Malignant germ cell tumour - considered - neoplastic
counterparts of the primordial germ cells /gonocytes present
during early embryonic development
•Syn – geminoma; ovary - dysgerminoma
GROSS MICRO:
IHC –
Positive – OCT3/4, SALL4, CD117, D2-40 (podoplanin),
SOX17, PLAP
Negative - HMW Keratin, CD30, SOX2, GATA3,
Glypican-3,
PLAP
Differential diagnosis
1. Solid pattern embryonal ca –
seminoma – prominent lymphocytic infiltrate;
+ve for KIT, Podoplanin, SOX17 ;
-ve for CD30, SOX2, Cytokeratin AE1/AE3
2. Solid yolk sac tumour -
yolk sac tumour patterns, less lymphocytes, and absence of fibrous septa
-ve for OCT3/4;
+ve for AFP ,glypican 3 & cytokeratin AE1/AE3
3. Choriocarcinoma
seminoma with syncytiotrophoblast – syncytiotrophoblast associated with seminoma
cells and not mononucleated trophoblasts (chorioca)
4. spermatocytic tumor
5. Malignant Sertoli cell tumor
Embryonalcarcinoma
•Malignant germ cell tumour composed of tumour
cells resembling embryonic stem cells
•Gross – Histo
•Patterns - Solid, glandular and papillary etc
combinations of two pattern - frequent
Positive
OCT3/4, SALL4, CD30, AE1/3, SOX2
Negative
CD117, D2-40, Glypican-3 , vimentin, podoplanin
Marker with normal tissues expressing type dd
Sox 2
Fetal CNS tissue
nuclear Embryonal carcinoma
PNET in teratoma
AE1/AE3 (pan cytokeratin cocktail)
Most epithelial cells
cytoplasmic Used with conjugation with CAM5.2
to screen carcinomas
Yolksac tumour, postpubertal-type
•Malignant GCT that differentiates to resemble
extraembryonic structures- yolk sac, allantois,
and extraembryonic mesenchyme
•Gross
•Microscopy – various patterns –microcystic, reticular, macrocystic, endodermal sinus pattern
(Schiller- Duval bodies) papillary, glandular, myxomatous
•Uncommon – polyvesicular vitelline, hepatoid and Intestinal
•Intracytoplasmic and extracellular hyaline globules (refractile eosinophilic)
•Band-like intercellular deposits of basement membrane - parietal differentiation.
IHC –
Positive - Glypican-3, SALL4, AE1/3, GATA-3, AFP(V),
PLAP (V)
Negative OCT4, CD30,hCG
Marker with normal tissues expressing type dd
Glypican – 3
By- embroyonic liver, placenta
(syntiotrophoblast)
Cytoplasmic,
membranous,
canlicular
HCC
Hepatoblastoma
Yolk sac tumor
Choriocarcinoma
Placental ste trophoblastic tumor
AFP
Fetal liver
Cytoplasmic Yolk sac tumor
OTHERS :HCC
HEPATOBLASTOMA
GATA -3
Involved in the luminal differentiation of
breast epithelium, development of
collecting system / urothelium and
trophoblastic differentiation
nuclear renal tumors
Paragangliomas
Choriocarcinomas
Mesotheliomas
yst
TROPHOBLASTICTUMOR
Choriocarcinoma
Malignant GCT that differentiates to resemble the
trophoblastic cells of the extraembryonic chorion –
cytotrophoblast, intermediate trophoblast, and
syncytiotrophoblast
Gross - Micro -
Positive - b- HCG, SALL4, Glypican-3,
AE1/3, GATA-3,PLAP
Negative - OCT4, CD30
Non-choriocarcinoma trophoblastic tumors:
•GCTS showing trophoblastic differentiation other than choriocarcinoma and
non-trophoblastic contaning syntiotrophoblasts
• Cystic trophoblastic tumor – post therapy
• Epithelioid trophoblastic tumour
• Placental site trophoblastic tumour,
• Regressing choriocarcinoma,
• Hybrid trophoblastic tumours.
Positive stain - Beta hydroxysteroid dehydrogenase, Inhibin, GATA 3 & CK 18
Marker with normal tissues expressing type dd
Hcg (human chrionic gonadotrophin)
syntiotrophoblast
cytoplasmic • Choriocarcinoma
• Syntiotrophoblast gaint cells in
seminoma
Inhibin
Granulosa cell, Sertoli cells, adrenal cortical
cells, trophoblasts
cytoplasmic • Adrenocortical neoplasm
• Sex cord stromal tumors
• Trophoblastic tumors
• Hemangioblastoma
Teratoma
postpubertal-type
Malignant GCT composed of several types of tissue
representing one or more of the germinal layers
endoderm, mesoderm & ectoderm
syn – mature teratoma, immature teratoma
Gross
Micro - any epithelial or mesenchymal tissue type can
be seen, as can neural tissue.; cytological atypia
• IHC- glandular element- epithelial membrane antigen, HCG (syntiotrophoblast), PLAP
(glandular structures)
Histologically different from prepubertal
Solid appearance
Disordered arrangement of tissues
Atypia and mitosis
Associated to GCNIS (Primary criteria for distinction between pre and postpubertal)
TERATOMAS WITH SOMATIC TYPE MALIGNANCY
•Develops a distinct secondary component that resembles somatic-type malignant
neoplasm (eg. Sarcomas and carcinomas)
•GROSS- grey white nodule, with necrosis and haemorrhage
•HISTO : Expansile/infiltrative growth patterns. Organoid admixtures of varied elements
admixed with GCT components.
• PNET another m/c to be found
• Adult type: Neuroendocrine tumors (carcinoids), carcinomas.
• IHC – similar to the counter parts in other organs
PLAP, OCT3/4, ALPHA FETO protein
TABLE
Mixedgermcell tumour
•Contains 2 or more malignant GCT components
•Most frequent combination: Embryonal Ca with teratoma,
seminoma and/or yolk sac
•Combination of prepubertal teratoma and yolk sac tumor is
not considered mixed GCT
•Gross – variegated appearance depending upon the
components present
MICRO:
A cystic glands of embryonal carcinoma with a more subtle
microcystic yolk sac tumour component.
B Polyembryoma variant of a mixed germ cell tumour forms
embryo-like bodies with a core of embryonal carcinoma, an
amniotic-like space, and a "ventral" yolk sac tumour component
C Diffuse embryoma. A diffuse embryoma variant of a mixed
germ cell tumour shows a necklace-like arrangement of
columnar embryonal carcinoma cells with a parallel component
of flat yolk sac tumour cells.
IHC – {{ OCT3/4 (Embroynal ccomponent
positive,yolk sac negative) , CD30, CK 7, NANOG}} ,
GLYPICAN 3, cd117(yst), SALL4(both +),
B-HCG
PUT ALGORITH
GERM CELL TUMORS UNRELATED
TO GERM CELL NEOPLASIA IN SITU
Prepubertal type GCN
SPERMATOCYTIC TUMOR
•From post pubertal type germ cells
•FGFR3 and HRAS gene mutation
•IHC-SALL4, CD117(50%), NUT(nuclear protein in testis), GAGE7, NY-ESO1, GAGE1, MAGEA 3, MAGEA 4, MAGEC1
• OCT4, CD30, AFP, PLAP, hCG, calret
TABLE OF DIFFRENCE BETWEEN 2
TERATOMA, PREPUBERTAL- TYPE
Composed of somatic tissues derived from one or more germinal layer.
SIMILAR TO MATURE CYSTIC TERATOMA OF OVARY
Gross and micro:
MIXED TERATOMA AND YOLK SAC TUMOR,
PREPUBERTAL
Gross- resembles prepubertal teratoma
Micro-
IHC- AFP (YST COMPONET),
Pre pubertal Yolk Sac tumor
m/c tesisticular GCT in infants and children
Histologically, identical to postpubertal type
SAME IHC PROFILE AS POST-PUBERTAL YST
SEX CORD-STROMAL TUMORS
2-5% Of testicular neoplasm
LEYDIG CELL TUMOR
Gross-
REINKE CRYSTAL,
LIPOFUSCHIN
PIGMENT
IHC- lnhibin, calretinin, SF1 , melan A, and C D99 are
typically positive. Chromogranin , synaptophysin, and cytokeratins are variably expressed, and
< 10% of tumours are S 1 00 protein-positive
Dd- Congenital adrenal hyperplasia (testicular adrenal rest tumours)
SERTOLI CELL, NOS
is a neoplasm composed of sex cord cells that usually shows focal tubular differentiation
but rarely grows diffusely.
GROSS- 2-5cms, well circumscribed with uniform yellow cut surface
HISTO-
IHC- Inhibin (50%) nuclear beta catenin (60-70%) , calretinin, SF1, CD99, melan A, WT1
vimentin, s100, sox9 (few)
LARGE CELL CALCIFYING SERTOLI CELL TUMOR
Composed of abundant eosinophilic cytoplasm and focal to massive calcifications.
PRKAR1A germ line mutation (60-70%)
GROSS- 1-15cms, tan to white, gritty, necrosis and haemorrhage
HISTO-
IHC- INHIBIN, s100, SF1, beta-catenin
INTRATULAR LARGE CELL HYALINIZING SERTOLI CELL NEOPLASIA
Occurs exclusively in paitents with Peutz – Jeghers syndrome
GROSS- Scattered firm foci measuring few mm in diameters
HISTO-
IHC- Inhibin, aromatase, cytokeratin
GRANULOSA CELL TUMOR- ADULT
•Neoplasm composed of sex cord cells that resemble granulosa cells of Graafian follicles of
ovary.
GROSS- well circumscribed, solid,sometimes cyst, c/s- lobulated yellowish tan.
MICRO-
IHC- VIMENTIN, calretinin , CD99, melan A, FOXL2, smooth muscle actin, S100
nuclear beta catenin
JUVENILE GRANULOSA CELL TUMOR
Shows solid and follicular patterns with immature nuclei
GROSS- well circumscribed, solid, cystic , yellow to tan-white
MICRO-
IHC- Inhibin, calretinin, CD99, SOX9, VIMENTIN, PANCYTOKERATIN, SMOOTH MUSCLE ACTIN
TUMOR CONTAINING BOTH GERM CELL AND
SEX CORD STROMAL TUMOR ELEMENTS
GONADOBLASTOMA
Arise from dysgenetic gonad
Restis-specific protein Y-encoded (TSPY) gene involved
GROSS-granular, gritty c/s- calcifications
HISTO- Spindle cell gonadal stroma , occasional
Leydig like cells lacking reinke crystal.
IHC-OCT3/4, FOXL2 (does not stain Sertoli cells of GCNIS THUS DIFFRENTIATE FROM
GCNIS) SEC CORD CELLS ( staing for alpha-inhibin, calretinin, FOXL2) and absence of
infiltrating lymphocytes distingyush from dysgerminoma/seminoma.
HEMATOLYMPHOID TUMORS
METASTATIC TUMOR
Secondary tumours coming from direct spread or distant metastasis
REFERENCES:

More Related Content

What's hot

immunotherapy and PDL1 IHC
immunotherapy and PDL1 IHCimmunotherapy and PDL1 IHC
immunotherapy and PDL1 IHC
kanwalpreet15
 
The 5th edition of the World Health Organization Classification of Haematolym...
The 5th edition of the World Health Organization Classification of Haematolym...The 5th edition of the World Health Organization Classification of Haematolym...
The 5th edition of the World Health Organization Classification of Haematolym...
Dr Seena Tresa Samuel
 
Bethesda system for reporting thyroid cytology
Bethesda system for reporting thyroid cytologyBethesda system for reporting thyroid cytology
Bethesda system for reporting thyroid cytology
ariva zhagan
 
Plasma cell Neoplasms 2021.pdf
Plasma cell Neoplasms 2021.pdfPlasma cell Neoplasms 2021.pdf
Plasma cell Neoplasms 2021.pdf
Mohamed Shaheen
 
cytology of the breast
cytology of the breastcytology of the breast
cytology of the breast
Hayelom kassaye
 
Grossing thyroid gland
Grossing thyroid glandGrossing thyroid gland
Grossing thyroid gland
Sansar Babu Tiwari
 
papillary lesions of the breast.pptx
papillary lesions of the breast.pptxpapillary lesions of the breast.pptx
papillary lesions of the breast.pptx
SirnaEmana1
 
Common pitfalls in bone marrow biopsy based diagnostic approach
Common pitfalls in bone marrow biopsy based diagnostic approachCommon pitfalls in bone marrow biopsy based diagnostic approach
Common pitfalls in bone marrow biopsy based diagnostic approach
spa718
 
NEW UPDATES IN KIDNEY TUMOR PATHOLOGY: WHO 5th EDITION.pptx
NEW UPDATES IN KIDNEY TUMOR PATHOLOGY: WHO 5th EDITION.pptxNEW UPDATES IN KIDNEY TUMOR PATHOLOGY: WHO 5th EDITION.pptx
NEW UPDATES IN KIDNEY TUMOR PATHOLOGY: WHO 5th EDITION.pptx
AnjalyNarendran
 
Myeloprolmiferative Neoplasms (2021)
Myeloprolmiferative Neoplasms (2021)Myeloprolmiferative Neoplasms (2021)
Myeloprolmiferative Neoplasms (2021)
Ahmed Makboul
 
Plasma cell neoplasms
Plasma cell neoplasmsPlasma cell neoplasms
Plasma cell neoplasms
Susheel Kumar Yeshala
 
Approach to lymphnode pathology
Approach to lymphnode pathologyApproach to lymphnode pathology
Approach to lymphnode pathology
nehaneemat
 
Grossing colon.pptx
Grossing colon.pptxGrossing colon.pptx
Grossing colon.pptx
Shahin Hameed
 
Pediatric Renal Tumors
Pediatric Renal TumorsPediatric Renal Tumors
Pediatric Renal Tumors
Utsab Das
 
Dr shashi bansal approch to bone marrow examination
Dr shashi bansal  approch to bone marrow examinationDr shashi bansal  approch to bone marrow examination
Dr shashi bansal approch to bone marrow examination
Shashi Bansal
 
Approach to undifferentiated tumors
Approach to undifferentiated tumorsApproach to undifferentiated tumors
Approach to undifferentiated tumors
Dr. Varughese George
 
Role of ihc on soft tissue tumours
Role of ihc on soft tissue tumoursRole of ihc on soft tissue tumours
Role of ihc on soft tissue tumours
ariva zhagan
 
Immunohistochemistry in breast lesions
Immunohistochemistry in breast lesionsImmunohistochemistry in breast lesions
Immunohistochemistry in breast lesions
Ashish Jawarkar
 
Approach to lymphoma
Approach to lymphomaApproach to lymphoma
Approach to lymphoma
GarimaAgarwalSUSMRAs
 
Eosinophils in lymph node
Eosinophils in lymph nodeEosinophils in lymph node
Eosinophils in lymph node
Monika Nema
 

What's hot (20)

immunotherapy and PDL1 IHC
immunotherapy and PDL1 IHCimmunotherapy and PDL1 IHC
immunotherapy and PDL1 IHC
 
The 5th edition of the World Health Organization Classification of Haematolym...
The 5th edition of the World Health Organization Classification of Haematolym...The 5th edition of the World Health Organization Classification of Haematolym...
The 5th edition of the World Health Organization Classification of Haematolym...
 
Bethesda system for reporting thyroid cytology
Bethesda system for reporting thyroid cytologyBethesda system for reporting thyroid cytology
Bethesda system for reporting thyroid cytology
 
Plasma cell Neoplasms 2021.pdf
Plasma cell Neoplasms 2021.pdfPlasma cell Neoplasms 2021.pdf
Plasma cell Neoplasms 2021.pdf
 
cytology of the breast
cytology of the breastcytology of the breast
cytology of the breast
 
Grossing thyroid gland
Grossing thyroid glandGrossing thyroid gland
Grossing thyroid gland
 
papillary lesions of the breast.pptx
papillary lesions of the breast.pptxpapillary lesions of the breast.pptx
papillary lesions of the breast.pptx
 
Common pitfalls in bone marrow biopsy based diagnostic approach
Common pitfalls in bone marrow biopsy based diagnostic approachCommon pitfalls in bone marrow biopsy based diagnostic approach
Common pitfalls in bone marrow biopsy based diagnostic approach
 
NEW UPDATES IN KIDNEY TUMOR PATHOLOGY: WHO 5th EDITION.pptx
NEW UPDATES IN KIDNEY TUMOR PATHOLOGY: WHO 5th EDITION.pptxNEW UPDATES IN KIDNEY TUMOR PATHOLOGY: WHO 5th EDITION.pptx
NEW UPDATES IN KIDNEY TUMOR PATHOLOGY: WHO 5th EDITION.pptx
 
Myeloprolmiferative Neoplasms (2021)
Myeloprolmiferative Neoplasms (2021)Myeloprolmiferative Neoplasms (2021)
Myeloprolmiferative Neoplasms (2021)
 
Plasma cell neoplasms
Plasma cell neoplasmsPlasma cell neoplasms
Plasma cell neoplasms
 
Approach to lymphnode pathology
Approach to lymphnode pathologyApproach to lymphnode pathology
Approach to lymphnode pathology
 
Grossing colon.pptx
Grossing colon.pptxGrossing colon.pptx
Grossing colon.pptx
 
Pediatric Renal Tumors
Pediatric Renal TumorsPediatric Renal Tumors
Pediatric Renal Tumors
 
Dr shashi bansal approch to bone marrow examination
Dr shashi bansal  approch to bone marrow examinationDr shashi bansal  approch to bone marrow examination
Dr shashi bansal approch to bone marrow examination
 
Approach to undifferentiated tumors
Approach to undifferentiated tumorsApproach to undifferentiated tumors
Approach to undifferentiated tumors
 
Role of ihc on soft tissue tumours
Role of ihc on soft tissue tumoursRole of ihc on soft tissue tumours
Role of ihc on soft tissue tumours
 
Immunohistochemistry in breast lesions
Immunohistochemistry in breast lesionsImmunohistochemistry in breast lesions
Immunohistochemistry in breast lesions
 
Approach to lymphoma
Approach to lymphomaApproach to lymphoma
Approach to lymphoma
 
Eosinophils in lymph node
Eosinophils in lymph nodeEosinophils in lymph node
Eosinophils in lymph node
 

Similar to Role of ihc in testicular tumors

Testicular tumors.pptx
Testicular tumors.pptxTesticular tumors.pptx
Testicular tumors.pptx
Utkarsh Singhal
 
kidney tumors.pptx
kidney tumors.pptxkidney tumors.pptx
kidney tumors.pptx
MeethuRappai1
 
Carcinoma of Unknown Primary (COUP)
Carcinoma of Unknown Primary (COUP)Carcinoma of Unknown Primary (COUP)
Carcinoma of Unknown Primary (COUP)
Dr.Shriniwas Bhawana Rishi
 
5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx
SAMOEINESH
 
5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx
SAMOEINESH
 
TESTICULAR TUMOURS
TESTICULAR TUMOURSTESTICULAR TUMOURS
TESTICULAR TUMOURS
Dr. Roopam Jain
 
Hepatocellularcarcinoma Updates
Hepatocellularcarcinoma UpdatesHepatocellularcarcinoma Updates
Hepatocellularcarcinoma Updates
Ipsita Panda
 
TESTICULAR TUMOURS & MALIGNANT TUMOUR OF PENIS
TESTICULAR TUMOURS & MALIGNANT TUMOUR OF PENISTESTICULAR TUMOURS & MALIGNANT TUMOUR OF PENIS
TESTICULAR TUMOURS & MALIGNANT TUMOUR OF PENIS
Dr. Roopam Jain
 
MALE GENITAL SYSTEM - TESTICULAR TUMOURS
MALE GENITAL SYSTEM - TESTICULAR TUMOURSMALE GENITAL SYSTEM - TESTICULAR TUMOURS
MALE GENITAL SYSTEM - TESTICULAR TUMOURS
Dr. Roopam Jain
 
MALE GENITAL TRACT – TESTICULAR TUMORS
MALE GENITAL TRACT – TESTICULAR TUMORSMALE GENITAL TRACT – TESTICULAR TUMORS
MALE GENITAL TRACT – TESTICULAR TUMORS
Dr. Roopam Jain
 
LOWER URINARY TRACT & MALE GENITAL SYSTEM
LOWER URINARY TRACT & MALE GENITAL SYSTEMLOWER URINARY TRACT & MALE GENITAL SYSTEM
LOWER URINARY TRACT & MALE GENITAL SYSTEM
Dr. Roopam Jain
 
neoplasia.pptx
neoplasia.pptxneoplasia.pptx
neoplasia.pptx
libin1986
 
Testicular ca [edmond]
Testicular ca [edmond]Testicular ca [edmond]
Testicular ca [edmond]
Edmond Wong
 
Thyroid Neoplasms an update based on latest WHO
Thyroid Neoplasms an update based on latest WHOThyroid Neoplasms an update based on latest WHO
Thyroid Neoplasms an update based on latest WHO
Vivekanand A
 
Ovary slide share 2
Ovary slide share 2Ovary slide share 2
Ovary slide share 2
Aksharaditya Shukla
 
GROUP 1 Case 967-- A Teenage Female with an Ovarian MassCLI.docx
GROUP 1 Case 967-- A Teenage Female with an Ovarian MassCLI.docxGROUP 1 Case 967-- A Teenage Female with an Ovarian MassCLI.docx
GROUP 1 Case 967-- A Teenage Female with an Ovarian MassCLI.docx
gilbertkpeters11344
 
NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...
NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...
NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...
Dr. Roopam Jain
 
Immunohistochemical diagnosis of carcinoma from an unkown primary
Immunohistochemical diagnosis of carcinoma from an unkown primaryImmunohistochemical diagnosis of carcinoma from an unkown primary
Immunohistochemical diagnosis of carcinoma from an unkown primary
krish penugonda
 
Carcinoma of unknown primary
Carcinoma of unknown primaryCarcinoma of unknown primary
Carcinoma of unknown primary
Archer Review USMLE and NCLEX
 
Liver 3
Liver 3Liver 3

Similar to Role of ihc in testicular tumors (20)

Testicular tumors.pptx
Testicular tumors.pptxTesticular tumors.pptx
Testicular tumors.pptx
 
kidney tumors.pptx
kidney tumors.pptxkidney tumors.pptx
kidney tumors.pptx
 
Carcinoma of Unknown Primary (COUP)
Carcinoma of Unknown Primary (COUP)Carcinoma of Unknown Primary (COUP)
Carcinoma of Unknown Primary (COUP)
 
5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx
 
5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx
 
TESTICULAR TUMOURS
TESTICULAR TUMOURSTESTICULAR TUMOURS
TESTICULAR TUMOURS
 
Hepatocellularcarcinoma Updates
Hepatocellularcarcinoma UpdatesHepatocellularcarcinoma Updates
Hepatocellularcarcinoma Updates
 
TESTICULAR TUMOURS & MALIGNANT TUMOUR OF PENIS
TESTICULAR TUMOURS & MALIGNANT TUMOUR OF PENISTESTICULAR TUMOURS & MALIGNANT TUMOUR OF PENIS
TESTICULAR TUMOURS & MALIGNANT TUMOUR OF PENIS
 
MALE GENITAL SYSTEM - TESTICULAR TUMOURS
MALE GENITAL SYSTEM - TESTICULAR TUMOURSMALE GENITAL SYSTEM - TESTICULAR TUMOURS
MALE GENITAL SYSTEM - TESTICULAR TUMOURS
 
MALE GENITAL TRACT – TESTICULAR TUMORS
MALE GENITAL TRACT – TESTICULAR TUMORSMALE GENITAL TRACT – TESTICULAR TUMORS
MALE GENITAL TRACT – TESTICULAR TUMORS
 
LOWER URINARY TRACT & MALE GENITAL SYSTEM
LOWER URINARY TRACT & MALE GENITAL SYSTEMLOWER URINARY TRACT & MALE GENITAL SYSTEM
LOWER URINARY TRACT & MALE GENITAL SYSTEM
 
neoplasia.pptx
neoplasia.pptxneoplasia.pptx
neoplasia.pptx
 
Testicular ca [edmond]
Testicular ca [edmond]Testicular ca [edmond]
Testicular ca [edmond]
 
Thyroid Neoplasms an update based on latest WHO
Thyroid Neoplasms an update based on latest WHOThyroid Neoplasms an update based on latest WHO
Thyroid Neoplasms an update based on latest WHO
 
Ovary slide share 2
Ovary slide share 2Ovary slide share 2
Ovary slide share 2
 
GROUP 1 Case 967-- A Teenage Female with an Ovarian MassCLI.docx
GROUP 1 Case 967-- A Teenage Female with an Ovarian MassCLI.docxGROUP 1 Case 967-- A Teenage Female with an Ovarian MassCLI.docx
GROUP 1 Case 967-- A Teenage Female with an Ovarian MassCLI.docx
 
NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...
NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...
NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...
 
Immunohistochemical diagnosis of carcinoma from an unkown primary
Immunohistochemical diagnosis of carcinoma from an unkown primaryImmunohistochemical diagnosis of carcinoma from an unkown primary
Immunohistochemical diagnosis of carcinoma from an unkown primary
 
Carcinoma of unknown primary
Carcinoma of unknown primaryCarcinoma of unknown primary
Carcinoma of unknown primary
 
Liver 3
Liver 3Liver 3
Liver 3
 

Recently uploaded

Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 

Recently uploaded (20)

Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 

Role of ihc in testicular tumors

  • 1. ROLE OF IHC IN TESTICULAR TUMORS BY: DR. PRERNA CHOUDHARY
  • 2. TESTIS- ANATOMYandHISTOLOGY Measures- 4.5 X 2.5 X 3 cm ; weighs:20 gram
  • 3. INTRODUCTION •Testicular cancers are the most common solid malignancy and the second leading cause of cancer death in young men •Affecting males between the ages of 15 and 35, although they represent only approximately 1 percent of all solid tumors in men •The are classified as per WHO CLASSIFICATION OF TUMORS OF TESTIS 2016 •THE H&E is gold standard for diagnosis, IHC plays a significant role and <5% of tumors require Immunostaining for accurate interpretation. •Differential diagnosis can be resolved with IHC •BUT, few pre-analytical errors to be kept in mind
  • 4.
  • 5. PREANALYTICAL ERRORS IHC is very important for diagnosis of type of cancer, however there can few errors which give false results FALSE NEGATIVE: Antibody inappropriate, denatured , used at wrong concentration Loss of antigen through poor fixation/diffusion. Presence of antigen at a density below level of detection. FALSE POSITIVES: Cross- reactivity of antibody with unintended antigens Nonspecific binding of the antibody to the tissue Presence of endogenous peroxidase Entrapment of normal tissues by tumor cells
  • 7.
  • 8.
  • 10. GERM CELL NEOPLASIA IN SITU •Syn – Intratubular germ cell neoplasia, unclassified; testicular intraepithelial neoplasia •Derived from primordial germ cells/gonocytes that failed to differentiate into spermatogonia • Adult testis – inside seminiferous tubules, between sertoli cell and basal membrane; •infantile testis - GCINS cells detached from basal membrane •No. tubules affected – few to 100% (variable) •Gonocyte-like germ cells - clear cytoplasm; angulated nuclei; coarse chromatin ,base of tubules •Nuclei - string of beads – separated from the lumen of tubule – by uniform sertoli cell nuclei
  • 11. IHC – PLAP (cytoplasmic), OCT3/4(NUCLEAR), Podoplanin, NANOG, LIN28 (absent – normal spermatogonia), SALL4 KIT(CD117) – non specific; normal spermatogonia – may be positive (cytoplasmic membrane) Frozen section – Alkaline phosphatase – helpful EMA, CD30, GLYPICAN 3, SOX2
  • 12. •DD Vacolization of seminiferous tubule cells (degenerative change) Maturation arrest in spermatogonia Metastatic carcinoma- melanoma, lymphoma may colonize seminiferous tubules OCT ¾ - resolve this matter
  • 13. Marker with normal tissues expressing type dd Oct ¾ (Octamer-binding transcription factor 4) Is not expressed in normal, differentiated cells nuclear • Highly sensitive and specific for seminoma • Poor prognostic factor for esophageal squamous cell carcinoma • May be poor prognostic factor for non-small cell lung cancer • MAY LOOSE REACTIVITY AFTER CHEMOTHERAPY PLAP (Placental Alkaline Phosphatase) placenta Cytoplasmic • Germ cell tumors(does not stain spermatocytic seminoma) • Intratubular germ cell neoplasia • Trophoblastic tumors • Serum PLAP is increased 10 fold in smokers- so not always included in diagnostic workup Podoplanin (D2-40) Novel marker of mesothelial cells, germ cells, lymphatic endothelial cells membranous Seminoma (100%) Embroyonal carcinoma (30%) Others: mesothelioma dermatofibroma Hemangioblastoma Primary skin adnexal tumor
  • 14. Marker with normal tissues expressing type dd SALL4 Embryonic stem cells Nuclear Pan germ cell tumor marker CD117(stem cell factor receptor) Germ cells Cytoplasmic and membranous • Seminoma • Intratubular germ cell neoplasia Others: Gist PEComas Oncocytomas CD 30 Membranous and golgi(paranuclear dot like) Embryonal carcinoma
  • 15. Specificforms – Intratubulargermcellneoplasia Intratubular seminoma – complete filling of tubules by neoplastic cells (identical to seminoma, GCINS), lymphocytes present IHC – simillar to seminoma Intratubular non – seminoma – almost always embryonal carcinoma Distortion of tubules , enlarged beyond normal diameter, necrosis, calcification IHC – OCT3/4 +, CD 30 +, CD 117 – (CD 30 is negative in GCNIS)
  • 16. INVASIVE GCN- single histological type
  • 17. Seminoma •Malignant germ cell tumour - considered - neoplastic counterparts of the primordial germ cells /gonocytes present during early embryonic development •Syn – geminoma; ovary - dysgerminoma GROSS MICRO:
  • 18.
  • 19. IHC – Positive – OCT3/4, SALL4, CD117, D2-40 (podoplanin), SOX17, PLAP Negative - HMW Keratin, CD30, SOX2, GATA3, Glypican-3, PLAP
  • 20. Differential diagnosis 1. Solid pattern embryonal ca – seminoma – prominent lymphocytic infiltrate; +ve for KIT, Podoplanin, SOX17 ; -ve for CD30, SOX2, Cytokeratin AE1/AE3 2. Solid yolk sac tumour - yolk sac tumour patterns, less lymphocytes, and absence of fibrous septa -ve for OCT3/4; +ve for AFP ,glypican 3 & cytokeratin AE1/AE3 3. Choriocarcinoma seminoma with syncytiotrophoblast – syncytiotrophoblast associated with seminoma cells and not mononucleated trophoblasts (chorioca) 4. spermatocytic tumor 5. Malignant Sertoli cell tumor
  • 21. Embryonalcarcinoma •Malignant germ cell tumour composed of tumour cells resembling embryonic stem cells •Gross – Histo •Patterns - Solid, glandular and papillary etc combinations of two pattern - frequent
  • 22. Positive OCT3/4, SALL4, CD30, AE1/3, SOX2 Negative CD117, D2-40, Glypican-3 , vimentin, podoplanin
  • 23. Marker with normal tissues expressing type dd Sox 2 Fetal CNS tissue nuclear Embryonal carcinoma PNET in teratoma AE1/AE3 (pan cytokeratin cocktail) Most epithelial cells cytoplasmic Used with conjugation with CAM5.2 to screen carcinomas
  • 24. Yolksac tumour, postpubertal-type •Malignant GCT that differentiates to resemble extraembryonic structures- yolk sac, allantois, and extraembryonic mesenchyme •Gross
  • 25. •Microscopy – various patterns –microcystic, reticular, macrocystic, endodermal sinus pattern (Schiller- Duval bodies) papillary, glandular, myxomatous •Uncommon – polyvesicular vitelline, hepatoid and Intestinal •Intracytoplasmic and extracellular hyaline globules (refractile eosinophilic) •Band-like intercellular deposits of basement membrane - parietal differentiation.
  • 26.
  • 27.
  • 28. IHC – Positive - Glypican-3, SALL4, AE1/3, GATA-3, AFP(V), PLAP (V) Negative OCT4, CD30,hCG
  • 29. Marker with normal tissues expressing type dd Glypican – 3 By- embroyonic liver, placenta (syntiotrophoblast) Cytoplasmic, membranous, canlicular HCC Hepatoblastoma Yolk sac tumor Choriocarcinoma Placental ste trophoblastic tumor AFP Fetal liver Cytoplasmic Yolk sac tumor OTHERS :HCC HEPATOBLASTOMA GATA -3 Involved in the luminal differentiation of breast epithelium, development of collecting system / urothelium and trophoblastic differentiation nuclear renal tumors Paragangliomas Choriocarcinomas Mesotheliomas yst
  • 30. TROPHOBLASTICTUMOR Choriocarcinoma Malignant GCT that differentiates to resemble the trophoblastic cells of the extraembryonic chorion – cytotrophoblast, intermediate trophoblast, and syncytiotrophoblast Gross - Micro -
  • 31. Positive - b- HCG, SALL4, Glypican-3, AE1/3, GATA-3,PLAP Negative - OCT4, CD30
  • 32. Non-choriocarcinoma trophoblastic tumors: •GCTS showing trophoblastic differentiation other than choriocarcinoma and non-trophoblastic contaning syntiotrophoblasts • Cystic trophoblastic tumor – post therapy • Epithelioid trophoblastic tumour • Placental site trophoblastic tumour, • Regressing choriocarcinoma, • Hybrid trophoblastic tumours. Positive stain - Beta hydroxysteroid dehydrogenase, Inhibin, GATA 3 & CK 18
  • 33. Marker with normal tissues expressing type dd Hcg (human chrionic gonadotrophin) syntiotrophoblast cytoplasmic • Choriocarcinoma • Syntiotrophoblast gaint cells in seminoma Inhibin Granulosa cell, Sertoli cells, adrenal cortical cells, trophoblasts cytoplasmic • Adrenocortical neoplasm • Sex cord stromal tumors • Trophoblastic tumors • Hemangioblastoma
  • 34. Teratoma postpubertal-type Malignant GCT composed of several types of tissue representing one or more of the germinal layers endoderm, mesoderm & ectoderm syn – mature teratoma, immature teratoma Gross Micro - any epithelial or mesenchymal tissue type can be seen, as can neural tissue.; cytological atypia
  • 35. • IHC- glandular element- epithelial membrane antigen, HCG (syntiotrophoblast), PLAP (glandular structures) Histologically different from prepubertal Solid appearance Disordered arrangement of tissues Atypia and mitosis Associated to GCNIS (Primary criteria for distinction between pre and postpubertal)
  • 36. TERATOMAS WITH SOMATIC TYPE MALIGNANCY •Develops a distinct secondary component that resembles somatic-type malignant neoplasm (eg. Sarcomas and carcinomas) •GROSS- grey white nodule, with necrosis and haemorrhage •HISTO : Expansile/infiltrative growth patterns. Organoid admixtures of varied elements admixed with GCT components. • PNET another m/c to be found • Adult type: Neuroendocrine tumors (carcinoids), carcinomas. • IHC – similar to the counter parts in other organs PLAP, OCT3/4, ALPHA FETO protein
  • 37. TABLE
  • 38. Mixedgermcell tumour •Contains 2 or more malignant GCT components •Most frequent combination: Embryonal Ca with teratoma, seminoma and/or yolk sac •Combination of prepubertal teratoma and yolk sac tumor is not considered mixed GCT •Gross – variegated appearance depending upon the components present
  • 39. MICRO: A cystic glands of embryonal carcinoma with a more subtle microcystic yolk sac tumour component. B Polyembryoma variant of a mixed germ cell tumour forms embryo-like bodies with a core of embryonal carcinoma, an amniotic-like space, and a "ventral" yolk sac tumour component C Diffuse embryoma. A diffuse embryoma variant of a mixed germ cell tumour shows a necklace-like arrangement of columnar embryonal carcinoma cells with a parallel component of flat yolk sac tumour cells.
  • 40. IHC – {{ OCT3/4 (Embroynal ccomponent positive,yolk sac negative) , CD30, CK 7, NANOG}} , GLYPICAN 3, cd117(yst), SALL4(both +), B-HCG
  • 42. GERM CELL TUMORS UNRELATED TO GERM CELL NEOPLASIA IN SITU
  • 44. SPERMATOCYTIC TUMOR •From post pubertal type germ cells •FGFR3 and HRAS gene mutation •IHC-SALL4, CD117(50%), NUT(nuclear protein in testis), GAGE7, NY-ESO1, GAGE1, MAGEA 3, MAGEA 4, MAGEC1 • OCT4, CD30, AFP, PLAP, hCG, calret
  • 45. TABLE OF DIFFRENCE BETWEEN 2
  • 46. TERATOMA, PREPUBERTAL- TYPE Composed of somatic tissues derived from one or more germinal layer. SIMILAR TO MATURE CYSTIC TERATOMA OF OVARY Gross and micro:
  • 47. MIXED TERATOMA AND YOLK SAC TUMOR, PREPUBERTAL Gross- resembles prepubertal teratoma Micro- IHC- AFP (YST COMPONET),
  • 48. Pre pubertal Yolk Sac tumor m/c tesisticular GCT in infants and children Histologically, identical to postpubertal type SAME IHC PROFILE AS POST-PUBERTAL YST
  • 49. SEX CORD-STROMAL TUMORS 2-5% Of testicular neoplasm
  • 50. LEYDIG CELL TUMOR Gross- REINKE CRYSTAL, LIPOFUSCHIN PIGMENT
  • 51. IHC- lnhibin, calretinin, SF1 , melan A, and C D99 are typically positive. Chromogranin , synaptophysin, and cytokeratins are variably expressed, and < 10% of tumours are S 1 00 protein-positive Dd- Congenital adrenal hyperplasia (testicular adrenal rest tumours)
  • 52. SERTOLI CELL, NOS is a neoplasm composed of sex cord cells that usually shows focal tubular differentiation but rarely grows diffusely. GROSS- 2-5cms, well circumscribed with uniform yellow cut surface HISTO- IHC- Inhibin (50%) nuclear beta catenin (60-70%) , calretinin, SF1, CD99, melan A, WT1 vimentin, s100, sox9 (few)
  • 53.
  • 54. LARGE CELL CALCIFYING SERTOLI CELL TUMOR Composed of abundant eosinophilic cytoplasm and focal to massive calcifications. PRKAR1A germ line mutation (60-70%) GROSS- 1-15cms, tan to white, gritty, necrosis and haemorrhage HISTO- IHC- INHIBIN, s100, SF1, beta-catenin
  • 55. INTRATULAR LARGE CELL HYALINIZING SERTOLI CELL NEOPLASIA Occurs exclusively in paitents with Peutz – Jeghers syndrome GROSS- Scattered firm foci measuring few mm in diameters HISTO- IHC- Inhibin, aromatase, cytokeratin
  • 56. GRANULOSA CELL TUMOR- ADULT •Neoplasm composed of sex cord cells that resemble granulosa cells of Graafian follicles of ovary. GROSS- well circumscribed, solid,sometimes cyst, c/s- lobulated yellowish tan. MICRO- IHC- VIMENTIN, calretinin , CD99, melan A, FOXL2, smooth muscle actin, S100 nuclear beta catenin
  • 57. JUVENILE GRANULOSA CELL TUMOR Shows solid and follicular patterns with immature nuclei GROSS- well circumscribed, solid, cystic , yellow to tan-white MICRO- IHC- Inhibin, calretinin, CD99, SOX9, VIMENTIN, PANCYTOKERATIN, SMOOTH MUSCLE ACTIN
  • 58.
  • 59.
  • 60. TUMOR CONTAINING BOTH GERM CELL AND SEX CORD STROMAL TUMOR ELEMENTS GONADOBLASTOMA Arise from dysgenetic gonad Restis-specific protein Y-encoded (TSPY) gene involved GROSS-granular, gritty c/s- calcifications HISTO- Spindle cell gonadal stroma , occasional Leydig like cells lacking reinke crystal.
  • 61. IHC-OCT3/4, FOXL2 (does not stain Sertoli cells of GCNIS THUS DIFFRENTIATE FROM GCNIS) SEC CORD CELLS ( staing for alpha-inhibin, calretinin, FOXL2) and absence of infiltrating lymphocytes distingyush from dysgerminoma/seminoma.
  • 63.
  • 64.
  • 65. METASTATIC TUMOR Secondary tumours coming from direct spread or distant metastasis

Editor's Notes

  1. The testis is composed of lobules of seminiferous tubules, interlobular septa, the mediastinum testis, rete testis, the tunica albuginea, and tunica vaginalis. Normal seminiferous tubules have a basement membrane and a thin fibrous wall, and contain germ cells in various stages of maturation plus Sertoli cells. Blood vessels and lymphatics, mesenchymal supporting tissue, macrophages, and Leydig cells are contained within the intertubular interstitium. Lobules are separated from each other by fibrous interlobular septa, which contain blood vessels and lymphatics.
  2. FOR THE ACCURATE RESULT
  3. We will discuss about important ones
  4. So therefor preanytical errors are the first step to keep in mind for avoiding the error further workup.
  5. GCNIS originates from primordial germ cells or gonocyte blocked in its maturation to a prespermatogonia Polypoidization is an early step initiating GCNIS WHICH remain dormant until puberty, after puberty it progresses to seminoma by default pathway or reprogrammed to non-seminoma consisting of------ This is due to gain or loss in specific chromosome mentioned……. KIT mutation is recurrent finding GCNIS UNRELARED include prepubertal teratoma and spermatocytic tumor. Yolk sac prepubertal shows specific gains and loss and result from progression of teratoma spermatocytic occurs due to gain in ch.9
  6. List of tumor markers looking foreward to OCT 4 ONLY MARKS FETAL GERM CELL
  7. Plap – placental alkaline phosphatase Podoplanin –membranous- negative for EC Sall 4 – nuclear CD30 is positive in embroyonal, gypican in yst, sox 2 in yst Ema- metastatic high grade carcinoma
  8. 117 is non specific as at also stains immature Sertoli cells INRATUBULAR- TUBELES ARE EXPANDED , obliteration of normal components , including Sertoli cells, tubules surrounded by lymphocytes EMBRONAL CA- distortion og seminiferous tubules , enlarged beyond normal diameter, necrosis, clacification,
  9. Gross – solid, homogenous, lobulated, cream/tan or pale yellow, bulge on c/s. Necrosis, hemorrhage +/- MICRO --Monomorphic primitive germ cell and lymphocytes tumour cells - pale to clear cytoplasm, distinct cytoplasmic membranes, polygonal non overlapping nuclei, granular chromatin One or more large , centrally located nucleoli. Granulomatous reaction +/- Morphologic variants: microcystic, cribiform, solid tubular, interstitial --- same prognosis Syncytiotrophoblasts in 10-20% (OCT4 +) --- same prognosis Atypia --- same prognosis
  10. IHC algorithm for germ cell tumours Oct4 ACTS AS GATEKEEPER
  11. Nuclear – OCT3/4, SALL4, SOX17 Cytoplasmic membrane - KIT(CD117), PLAP, Podoplanin HMW KERATIN IS POSITIVE IN NON-SEMOINOMA GERM CELL TUMOR SOX 2 POSITIVE IN EMBROUONAL
  12. -GROSS enlarged testis ,variegated appearance, solid, white to tan, hemorrhagic, necrotic and cystic HISTO- large, pleomorphic vesicular nuclei, single or multiple macronucleoli, dense amphophilic cytoplasm, poorly defined cytoplasmic membranes, mitotic figures, apoptotic bodies. Nuclear crowding, pleomorphism
  13. Cd30, oct ¾, sox 2 (NUCLEAR) help to distinguish from gct REACTIVITY TO Cd30(membranos) disappears after chemo but oct3.4 persists
  14. Gross-- solid to partially cystic, usually with a greyish-white to tan cut surface may have a myxoid quality. haemorrhage and necrosis +/-
  15. a. gross b. Schiller duval bodies- endodermal sinus pattern c. Pleomorphism and hyaline globules in yolk sac tumor of testis.
  16. Yst gets differentiates into different pattern
  17. Glypican- membranous, cytoplasmic, afp- cytoplasmic, gata 3 nuclear
  18. Gross- haemorrhagic nodules containing foci of solid, greyish-tan tumour. Micro-biphasic appearance –mononucleated (cytotrophoblasts and intermediate trophoblasts) and multinucleated syncytiotrophoblasts - in a haemorrhagic background
  19. Syntiotrophoblast reactive to hcg Ae1/ae3 – cytoplasmic Cam5.2 is low molecular weight keratin.. Used along with ae1/3 to screen carcinoma Hcg- cytoplasmic ,
  20. Inhibin- cytoplasmic, gata- nuclear,
  21. - nodular and firm. The cut surfaces are heterogeneous with solid and cystic areas corresponding to the tissue types present histologically
  22. A teratoma with somatic-type malignancy is a teratoma that develops a distinct secondary component that resembles a somatic·type malignant neoplasm, as seen in other organs and tissues (e.g. sarcomas and ca1cinomas). sarcomas are most common; most common ca - adenoca
  23. SARCOMAS ( RHABDOMYOSARCOMA) are must common
  24. Closely associated with yst and embroyonal component
  25. Gross- 3-5cm, lobular to multinodular, c/s greyish white, fleshy to myxoid. OCT3/4, Placental alkaline phosphatase, alpha-fetoprotein, cd30 (negative) spermatogonia proteins expressed (MAGEA4, KIT, SAGE1, DMRT1, SALL4, OCT2)
  26. All non-seminoma gct is cytokeratin positive
  27. They lack cells with cytological atypia hich is seen germ cell associated teratoma
  28. Most tumours are 0. 5-5 cm and well circumscribed.They have a homogeneous ,soft, yellow t o tan or brownish-green cut surface, but haemorrhage and necrosis are seen in about 25% of them . Lobulation with visible wh ite bands between lobules may be present
  29. NESTS OF PALLISADING CELLS- CALL-EXNER LIKE ARRANGEMENT SERTOLI CELLS
  30. Sertoliform cells expresses sex cord stromal markers ---------------------------------------------------adenocarcinoma related markers